ALX ONCOLOGY HOLDINGS INC: current liabilities
Current liabilities for ALX ONCOLOGY HOLDINGS INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ALX ONCOLOGY HOLDINGS INC financial histories
What this measure means
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
Exact concept: us-gaap:LiabilitiesCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 24,553,000 | USD | 2026-03-09 | 10-K · 0001193125-26-098454 |
| At date | 2024-12-31 | 18,500,000 | USD | 2026-03-09 | 10-K · 0001193125-26-098454 |
| At date | 2023-12-31 | 36,001,000 | USD | 2025-03-06 | 10-K · 0000950170-25-034761 |
| At date | 2022-12-31 | 28,325,000 | USD | 2024-03-07 | 10-K · 0000950170-24-027955 |
| At date | 2021-12-31 | 15,295,000 | USD | 2023-03-09 | 10-K · 0000950170-23-007013 |
| At date | 2020-12-31 | 6,204,000 | USD | 2022-02-28 | 10-K · 0001564590-22-007364 |
| At date | 2019-12-31 | 4,984,000 | USD | 2021-03-18 | 10-K · 0001564590-21-014169 |
Related financial histories
- ALX ONCOLOGY HOLDINGS INC: total assets
- ALX ONCOLOGY HOLDINGS INC: total liabilities
- ALX ONCOLOGY HOLDINGS INC: stockholders equity
- ALX ONCOLOGY HOLDINGS INC: cash and cash equivalents
- ALX ONCOLOGY HOLDINGS INC: net income or loss
- ALX ONCOLOGY HOLDINGS INC: operating cash flow
- ALX ONCOLOGY HOLDINGS INC: capital expenditure payments
- ALX ONCOLOGY HOLDINGS INC: contract revenue excluding tax
- ALX ONCOLOGY HOLDINGS INC: financing cash flow
- ALX ONCOLOGY HOLDINGS INC: investing cash flow
- ALX ONCOLOGY HOLDINGS INC: retained earnings or deficit
- ALX ONCOLOGY HOLDINGS INC: basic weighted-average shares
- ALX ONCOLOGY HOLDINGS INC: diluted weighted-average shares
- ALX ONCOLOGY HOLDINGS INC: basic earnings per share
- ALX ONCOLOGY HOLDINGS INC: diluted earnings per share
- ALX ONCOLOGY HOLDINGS INC: income tax expense or benefit
- ALX ONCOLOGY HOLDINGS INC: net property, plant and equipment
- ALX ONCOLOGY HOLDINGS INC: share-based compensation expense
- ALX ONCOLOGY HOLDINGS INC: operating income or loss
- ALX ONCOLOGY HOLDINGS INC: current assets
- ALX ONCOLOGY HOLDINGS INC: interest expense
- ALX ONCOLOGY HOLDINGS INC: current accounts payable
- ALX ONCOLOGY HOLDINGS INC: operating expenses
- ALX ONCOLOGY HOLDINGS INC: research and development expense
Inspect the source
- Entity
- ALX ONCOLOGY HOLDINGS INC / CIK 0001810182
- Captured
- 2026-09-21T17:28:27.056Z
- SEC response SHA-256
b9bf33790517e21c75944ad52d55e7333561e134c2f4fb48852f7c51eb47246c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001810182.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))